viernes, 25 de enero de 2013

ALCON / Novartis en la mira de USA por "poner ojos" en Irán...

U.S. authorities are investigating the export of products made by Novartis AG's Alcon eye-care unit to various countries subject to U.S. trade sanctions, including Iran, Novartis said Wednesday. 

Alcon was notified during 2012 that the U.S. Attorney's Office for the Northern District of Texas is conducting the probe, Novartis disclosed in an annual report filed Wednesday with the U.S. Securities and Exchange Commission. 

Alcon received a grand-jury subpoena seeking documents dating back to 2005, in connection with the investigation, Novartis said. 

 Novartis spokesman Eric Althoff said Alcon is cooperating with the investigation and the company can't comment further on the specifics of the investigation. 

The U.S. has imposed sanctions that generally bar the export of goods and services to Iran from the U.S. or by Americans, with certain narrow exceptions, according to the U.S. Treasury Department's Office of Foreign Assets Control. (Más)


Ver también:

Novartis Draws U.S. Investigation Into Sales to Iran/Bloomberg
Publicar un comentario